Targeting xCT, a Cystine-Glutamate Transporter Induces Apoptosis and Tumor Regression for KSHV/HIV-associated Lymphoma

Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-7-30
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Fighting Breast Cancer Stem Cells Through the Immune-Targeting of the xCT Cystine–glutamate Antiporter

Cancer Immunology, Immunotherapy
Cancer ResearchMedicineOncologyAllergyImmunology
2018English

Cystine/Glutamate Antiporter (xCT) Is Required for Chief Cell Plasticity After Gastric Injury

Cellular and Molecular Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

The Glutamate/Cystine xCT Antiporter Antagonizes Glutamine Metabolism and Reduces Nutrient Flexibility

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2017English

Kaposi Sarcoma-Associated Herpesvirus (KSHV) Induces a Functional Tumor-Associated Phenotype for Oral Fibroblasts

Cancer Letters
Cancer ResearchOncology
2012English

The Cystine-Glutamate Exchanger (xCT, Slc7a11) Is Expressed in Significant Concentrations in a Subpopulation of Astrocytes in the Mouse Brain

GLIA
Molecular NeuroscienceNeurologyCellular
2018English

Intratumoral Injection of Ad-Isf35 (Chimeric CD154) Breaks Tolerance and Induces Lymphoma Tumor Regression

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2015English

Glutamate and Tumor-Associated Epilepsy

Oncotarget
Oncology
2011English

Targeting the PI3K/AKT/MTOR Pathway in KSHV-associated Cancers

Infectious Agents and Cancer
Cancer ResearchEpidemiologyOncologyInfectious Diseases
2009English

Extracavitary KSHV-positive Solid Lymphoma

American Journal of Surgical Pathology
AnatomyForensic MedicinePathologySurgery
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy